Connor, Clark & Lunn Investment Management Ltd. Amgen Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $21.8 Billion
  • Q1 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 42,902 shares of AMGN stock, worth $13.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
42,902
Previous 52,448 18.2%
Holding current value
$13.4 Million
Previous $15.1 Million 19.26%
% of portfolio
0.06%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $2.57 Million - $3.1 Million
-9,546 Reduced 18.2%
42,902 $12.2 Million
Q4 2023

Feb 09, 2024
BUY
$255.7 - $288.46 $13.1 Million - $14.8 Million
51,384 Added 4829.32%
52,448 $15.1 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $34.3 Million - $42.6 Million
-156,809 Reduced 99.33%
1,064 $285,000
Q2 2023

Aug 10, 2023
SELL
$214.27 - $253.37 $16.3 Million - $19.2 Million
-75,944 Reduced 32.48%
157,873 $35.1 Million
Q1 2023

May 09, 2023
BUY
$225.79 - $275.2 $33.8 Million - $41.2 Million
149,770 Added 178.2%
233,817 $56.5 Million
Q4 2022

Feb 10, 2023
BUY
$229.03 - $291.01 $15.8 Million - $20.1 Million
69,149 Added 464.15%
84,047 $22.1 Million
Q3 2022

Nov 10, 2022
SELL
$224.46 - $253.15 $17.2 Million - $19.4 Million
-76,674 Reduced 83.73%
14,898 $3.36 Million
Q2 2022

Aug 05, 2022
SELL
$230.71 - $256.74 $37.8 Million - $42.1 Million
-163,787 Reduced 64.14%
91,572 $22.3 Million
Q1 2022

May 12, 2022
BUY
$219.27 - $242.57 $41.5 Million - $45.9 Million
189,078 Added 285.27%
255,359 $61.8 Million
Q4 2021

Feb 10, 2022
BUY
$198.88 - $227.6 $8.13 Million - $9.31 Million
40,898 Added 161.12%
66,281 $14.9 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $1.28 Million - $1.5 Million
-6,049 Reduced 19.24%
25,383 $5.4 Million
Q2 2021

Aug 12, 2021
SELL
$233.58 - $259.14 $10.1 Million - $11.2 Million
-43,131 Reduced 57.85%
31,432 $7.66 Million
Q1 2021

May 13, 2021
BUY
$221.91 - $258.6 $3.62 Million - $4.21 Million
16,292 Added 27.96%
74,563 $18.6 Million
Q4 2020

Feb 16, 2021
SELL
$216.38 - $257.67 $1.68 Million - $2.01 Million
-7,787 Reduced 11.79%
58,271 $13.4 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $8.93 Million - $9.93 Million
38,071 Added 136.03%
66,058 $16.8 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $735,259 - $902,264
3,717 Added 15.32%
27,987 $6.6 Million
Q1 2020

May 13, 2020
SELL
$182.24 - $241.7 $1.85 Million - $2.45 Million
-10,139 Reduced 29.47%
24,270 $4.92 Million
Q4 2019

Feb 12, 2020
SELL
$189.21 - $243.2 $562,899 - $723,520
-2,975 Reduced 7.96%
34,409 $8.3 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $4.3 Million - $5.15 Million
-24,675 Reduced 39.76%
37,384 $7.23 Million
Q2 2019

Aug 07, 2019
BUY
$166.7 - $195.41 $5.35 Million - $6.27 Million
32,075 Added 106.97%
62,059 $11.4 Million
Q1 2019

May 08, 2019
SELL
$180.87 - $203.88 $25,502 - $28,747
-141 Reduced 0.47%
29,984 $5.7 Million
Q4 2018

Feb 12, 2019
SELL
$178.4 - $208.25 $39.4 Million - $45.9 Million
-220,575 Reduced 87.98%
30,125 $5.86 Million
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $21.4 Million - $24.1 Million
115,350 Added 85.22%
250,700 $52 Million
Q2 2018

Aug 02, 2018
BUY
$166.05 - $186.51 $651,746 - $732,051
3,925 Added 2.99%
135,350 $25 Million
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $2.6 Million - $3.04 Million
-15,375 Reduced 10.47%
131,425 $22.4 Million
Q4 2017

Feb 09, 2018
SELL
$168.79 - $188.59 $666,720 - $744,930
-3,950 Reduced 2.62%
146,800 $25.5 Million
Q3 2017

Nov 14, 2017
SELL
$167.29 - $191.0 $6.44 Million - $7.35 Million
-38,475 Reduced 20.33%
150,750 $28.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
189,225
189,225 $32.6 Million

Others Institutions Holding AMGN

# of Institutions
2,930
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email